Quetiapine-d4 hemifumarate

• CAT Number: S000148
• CAS Number: 1217310-65-0
• Molecular Formula: C23H23D4N3O4S
• Molecular Weight: 445.57
• Purity: ≥95%
• Target: Neuronal Signaling
• IUPAC Name: 2-[2-(4-benzo[b][1,4]benzothiazepin-6-ylpiperazin-1-yl)-1,1,2,2-tetradeuterioethoxy]ethanol
• InChI: InChI=1S/C21H25N3O2S/c25-14-16-26-15-13-23-9-11-24(12-10-23)21-17-5-1-3-7-19(17)27-20-8-4-2-6-18(20)22-21/h1-8,25H,9-16H2/i13D2,15D2
• InChIKey: URKOMYMAXPYINW-LXEIGJDRSA-N
• SMILES: [2H]C([2H])(C([2H])([2H])OCCO)N1CCN(CC1)C2=NC3=CC=CC=C3SC4=CC=CC=C42

Quetiapine-d4 hemifumarate (CAS: 1217310-65-0), a premium pharmaceutical research compound designed for advanced psychopharmacological and antipsychotic studies. As a deuterated analog of Quetiapine hemifumarate, it offers enhanced stability and improved pharmacokinetic properties. Quetiapine-d4 hemifumarate is ideal for use in pharmacological and biochemical research, providing precise and reliable data for your studies. This high-purity compound ensures consistent results, aiding in the development of novel therapies for schizophrenia, bipolar disorder, and other psychiatric conditions. Trusted by leading laboratories, Quetiapine-d4 hemifumarate is your go-to solution for cutting-edge mental health research. Unlock new possibilities in the treatment of psychiatric disorders with Quetiapine-d4 hemifumarate, where innovation meets reliability.

Reference

[1]. Cross AJ, et al. Quetiapine and its metabolite norquetiapine: translation from in vitro pharmacology to in vivo efficacy in rodent models. Br J Pharmacol. 2016 Jan;173(1):155-66.
[Content Brief]